Lee R, Kumar R, Weaver A, Kim J, Raza A, Ong J
Diagnostics (Basel). 2025; 15(5).
PMID: 40075889
PMC: 11899542.
DOI: 10.3390/diagnostics15050643.
Maglionico M, Lanzolla G, Figus M, Cosentino G, Comi S, Marino M
Front Endocrinol (Lausanne). 2024; 15:1428185.
PMID: 39713053
PMC: 11659954.
DOI: 10.3389/fendo.2024.1428185.
Kotak P, Kadam A, Acharya S, Kumar S, Varma A
Cureus. 2024; 16(10):e71126.
PMID: 39525250
PMC: 11544504.
DOI: 10.7759/cureus.71126.
Wang Y, Liu S, Lin G, Huang E, Keller J, Wang L
Clin Transl Sci. 2024; 17(10):e70039.
PMID: 39356083
PMC: 11445710.
DOI: 10.1111/cts.70039.
Kryszan K, Wylegala A, Kijonka M, Potrawa P, Walasz M, Wylegala E
Diagnostics (Basel). 2024; 14(7).
PMID: 38611606
PMC: 11011861.
DOI: 10.3390/diagnostics14070694.
THE EFFECT OF PALPEBRAL FISSURE HEIGHT IN PRIMARY GAZE POSITION ON TEAR FILM STABILITY.
covic A, Petricek I, Tomic M
Acta Clin Croat. 2024; 62(2):283-290.
PMID: 38549607
PMC: 10969636.
DOI: 10.20471/acc.2023.62.02.05.
Ocular surface and meibomian gland evaluation in euthyroid Graves' ophthalmopathy.
Lai K, Liao X, Aljufairi F, Sebastian J, Ma A, Man Wong Y
Int Ophthalmol. 2024; 44(1):124.
PMID: 38430354
PMC: 10908617.
DOI: 10.1007/s10792-024-02919-y.
Ocular Surface Disease Related to the Inflammatory and Non-Inflammatory Phases of Thyroid Eye Disease.
Riguetto C, Barbosa E, Atihe C, Reis F, Alves M, Zantut-Wittmann D
Clin Ophthalmol. 2023; 17:3465-3475.
PMID: 38026592
PMC: 10657741.
DOI: 10.2147/OPTH.S430861.
Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves' Ophthalmopathy.
You Y, Chen J, Chen H, Wang J, Xie H, Pi X
Transl Vis Sci Technol. 2023; 12(10):19.
PMID: 37889503
PMC: 10617636.
DOI: 10.1167/tvst.12.10.19.
Symptoms and signs of dry eye in children with Graves' ophthalmopathy.
Jankauskiene J, Jarusaitiene D
Saudi J Ophthalmol. 2023; 37(2):149-153.
PMID: 37492217
PMC: 10365247.
DOI: 10.4103/sjopt.sjopt_47_22.
Systemic investigations in dry eye disease.
DSouza S, James E, Jois R, Mahendradas P, Koul A, Pradhan A
Indian J Ophthalmol. 2023; 71(4):1326-1331.
PMID: 37026264
PMC: 10276668.
DOI: 10.4103/IJO.IJO_3003_22.
A clinical study of topical treatment for thyroid-associated ophthalmopathy with dry eye syndrome.
Sun R, Yang M, Lin C, Wu Y, Sun J, Zhou H
BMC Ophthalmol. 2023; 23(1):72.
PMID: 36803227
PMC: 9940084.
DOI: 10.1186/s12886-023-02805-8.
Prevalence of Dry Eye Symptoms and Associated Risk Factors among University Students in Poland.
Wrobel-Dudzinska D, Osial N, Stepien P, Gorecka A, Zarnowski T
Int J Environ Res Public Health. 2023; 20(2).
PMID: 36674068
PMC: 9859544.
DOI: 10.3390/ijerph20021313.
Ocular surface optimization before cataract surgery.
Venkateswaran N, Luna R, Gupta P
Saudi J Ophthalmol. 2022; 36(2):142-148.
PMID: 36211316
PMC: 9535908.
DOI: 10.4103/sjopt.sjopt_190_21.
Risk factors for development of superior limbic keratoconjunctivitis in thyroid eye disease in Japanese.
Takahashi Y, Vaidya A, Kakizaki H
Graefes Arch Clin Exp Ophthalmol. 2022; 261(3):833-839.
PMID: 36083323
DOI: 10.1007/s00417-022-05827-y.
The combination of T2-mapping value of lacrimal gland and clinical indicators can improve the stage prediction of Graves' ophthalmopathy compared to clinical activity scores.
Jiang M, Song X, Zhang H, Tao X, Yang G, Wang Y
Endocrine. 2022; 78(2):321-328.
PMID: 35997966
DOI: 10.1007/s12020-022-03167-9.
Comparison of the ocular surface microbiota between thyroid-associated ophthalmopathy patients and healthy subjects.
Ji X, Dong K, Pu J, Yang J, Zhang Z, Ning X
Front Cell Infect Microbiol. 2022; 12:914749.
PMID: 35959376
PMC: 9360483.
DOI: 10.3389/fcimb.2022.914749.
A case report of a patient with severe thyroid eye disease.
Macovei M, Azis U
Rom J Ophthalmol. 2022; 66(2):153-157.
PMID: 35935091
PMC: 9289779.
DOI: 10.22336/rjo.2022.30.
Changes in Dry Eye Status after Steroid Pulse and Orbital Radiation Therapies in Active Thyroid Eye Disease.
Takahashi Y, Vaidya A, Kakizaki H
J Clin Med. 2022; 11(13).
PMID: 35806890
PMC: 9267447.
DOI: 10.3390/jcm11133604.
Improvement of Ocular Surface Disease by Lateral Tarsoconjunctival Flap in Thyroid-Associated Orbitopathy Patients with Lid Retraction.
Hsu C, Hsieh M, Chang H, Chen Y, Chien K
J Pers Med. 2022; 12(5).
PMID: 35629224
PMC: 9146611.
DOI: 10.3390/jpm12050802.